[#item_full_content] Medicare is compensating healthcare providers who supply eligible patients with up to $500 annually of low-THC hemp products through its beneficiary engagement incentive program, though the program’s future is uncertain due to pending litigation and recent legislative changes to hemp definitions. The program, available through select Medicare innovation models, imposes strict requirements on clinicians including product eligibility limits, patient qualifications and quality standards.  Read More